Sponsor:
Janssen Research & Development, LLC
Code:
NCT04919512
Conditions
Urinary Bladder Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TAR-200
Cetrelimab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations